DIM Hormonal Balance.

Glucobrassicin is hydrolysed by myrosinase to indole-3-carbinol, which condenses in stomach acid to give diindolylmethane. Supplying the precursor feeds the same molecule the finished ingredient delivers directly.

Broccoli sprouts carry both glucobrassicin and glucoraphanin, so the extract supplies the indole precursor pool alongside the isothiocyanate one. The pairing covers the whole cruciferous set rather than one end product.

Sulforaphane activates Nrf2 and raises phase II conjugating enzymes such as glutathione S-transferase, while DIM works mainly through aryl hydrocarbon receptor signalling and phase I hydroxylation. Together they cover both arms of the same clearance pathway.

Calcium D-glucarate releases glucaro-1,4-lactone, which inhibits gut beta-glucuronidase and keeps glucuronide conjugates from being cleaved and taken back up. DIM shifts hydroxylation upstream, so the pair covers formation and then removal of the conjugate.

Catechol metabolites formed after hydroxylation are methylated by COMT using S-adenosylmethionine, which the folate cycle regenerates. Adequate methylfolate keeps that methyl supply available.

Methylcobalamin is the cofactor that lets methionine synthase pass a methyl group from folate to homocysteine, regenerating methionine and then SAMe. Without it the methyl donor pool COMT draws on runs down.

Betaine donates a methyl group to homocysteine through BHMT, a folate-independent path to methionine and then SAMe. It supports the same methylation capacity the catechol clearance step depends on.

COMT is a magnesium-dependent enzyme, so the methyl transfer onto catechol metabolites needs the ion present at the active site. Magnesium is the mineral half of that methylation step.

Diindolylmethane is the acid-catalysed condensation dimer of indole-3-carbinol, formed in the stomach after indole-3-carbinol is released from glucobrassicin. Taking indole-3-carbinol therefore produces a variable mix that includes DIM plus other oligomers, while taking DIM delivers the dimer directly. The two are the same pathway at different points and should be counted once.

Phase II conjugation of hydroxylated steroid and xenobiotic metabolites includes glutathione-S-transferase routes, and cysteine availability from NAC is the limiting input for glutathione synthesis. DIM is described as an inducer of phase II enzyme expression, so substrate supply sits downstream of that induction. This is enzyme-system logic rather than a measured combination.

Glutathione is the conjugating partner for reactive quinone metabolites generated when catechol oxidation follows hydroxylation. Where a compound shifts flux toward hydroxylated intermediates, conjugation capacity is what keeps the pathway moving. The pairing supports normal phase II handling and is not a claim about a hormone outcome.

Riboflavin supplies FAD to methylenetetrahydrofolate reductase, the step that feeds methyl groups toward methyltransferase reactions including catechol-O-methyltransferase. Methylation is a normal exit route for catechol metabolites of hydroxylation. Riboflavin therefore supports the same downstream capacity that folate and betaine do.

Choline oxidised to betaine donates a methyl group to homocysteine through betaine-homocysteine methyltransferase, an alternative to the folate route for regenerating methionine. Methionine is the source of the S-adenosylmethionine used by methyltransferases acting on catechol metabolites. This is settled one-carbon biochemistry.

Gut bacteria express beta-glucuronidase, which cleaves glucuronide conjugates in the intestinal lumen and returns the freed compound to circulation. Microbial composition therefore affects how much conjugated material stays conjugated. The direction of effect depends on the strains present, which is why this is held at Promising and framed as modulating.

Silymarin flavonolignans have described effects on UDP-glucuronosyltransferase and several cytochrome P450 isoforms, the same enzyme families that handle hydroxylation and conjugation of steroid metabolites. The net direction when stacked with an AhR-active compound is not predictable from mechanism alone. Named because the overlap is real, not because a combined result is known.

DIM is highly lipophilic and poorly water soluble, so plasma appearance depends heavily on the delivery system and on fat in the meal. A medium-chain triglyceride carrier gives the crystalline material a lipid phase to dissolve into. This is why absorption-enhanced DIM products exist at all.

Phospholipid dispersion is a standard route for getting a poorly soluble crystalline compound into a micellar form the intestine can take up. Microencapsulated and phospholipid-dispersed DIM exists for this reason. The effect is on delivery, not on what the molecule does once absorbed.

Lecithin acts as the emulsifier in many absorption-enhanced formats of lipophilic actives. Its contribution is physical dispersion of the crystal. Nothing here speaks to a hormonal effect.

Tocopherol and tocopheryl-polyethylene-glycol systems are used as lipid vehicles and solubilisers for fat-soluble actives, and they also slow oxidation of the carrier oil. The role is formulation. It says nothing about the active's own activity.

Piperine inhibits several UDP-glucuronosyltransferase and cytochrome P450 activities, which is how it raises plasma levels of some co-administered compounds. Whether that happens with DIM specifically has not been established, and slowing conjugation is not automatically desirable for a compound whose point is metabolite handling. Included as an interaction to be aware of rather than a pairing to recommend.

Caffeine is cleared mainly by CYP1A2, and aryl hydrocarbon receptor ligands are known inducers of the CYP1A family. A compound with AhR activity could therefore shift caffeine clearance. This is a mechanistic prediction, not a measured interaction, so it stays at Early.

Pyridoxal-5-phosphate has been described as a modulator of steroid hormone receptor transcriptional activity in laboratory work. That is a cell-level observation in a related area, not a demonstrated interaction with DIM. It is listed at Early so the mechanistic link is visible without being overstated.

Flaxseed carries lignans whose bacterial metabolites bind oestrogen receptors weakly, so it acts on receptor occupancy while DIM acts on metabolite handling and receptor signalling. Two different points on the same axis. The combined direction has not been characterised.